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INTRODUCTION AND OBJECTIVES:
In order to identify potential novel biomarkers of adrenocortical carcinoma (ACC), we reevaluated published message RNA (mRNA) expression profiling data.
METHODS: The mRNA expression profiles in ACC microarray dataset GSE33371were analyzed and an independent cohort of 44 clinical samples including 20 ACC and 24adrenocortical adenoma (ACA) patients were used to confirm the most statistically significant mRNAs which were related with poor prognosis of these patients by real time PCR. Next, the relationships between the selected mRNAs and ACC patients' clinicopathological features and prognosis were investigated.
RESULTS: The PCR results in a cohort of 20 ACC and 24 ACA tissues were used for confirmation of the selected three mRNAs (CDK1, OERRM2 and TOP2A). The PCR results showed that the expression of two mRNA (CDK1 and TOP2A) were significantly upregulated in ACC. KaplaneMeier analysis and univariate Cox regression indicated these two mRNA had significant hazard ratios for predicting clinical outcome. Spearman analysis showed that CDK1 expression was significantly correlated with TOP2A in our tissue. Based on the expression of these mRNA in our tissue, we established a set of two mRNAs signature that could also correlate with OS significantly in our tissues and GSE33371 test series.
CONCLUSIONS: mRNAs are involved in ACC carcinogenesis. Increased CDK1 and TOP2A expression and these two mRNAs signature may be adverse prognostic factors in ACC patients. METHODS: We investigated the expression profile of circRNAs in three primary ACC and three Adrenocortical adenoma (ACA) tumor samples using a high-throughput circRNA microarray. Bioinformatic analyses were applied to study these differentially expressed circRNAs. Furthermore, qRT-PCR was performed to confirm these results. The expression levels and functions of circ0066659 were evaluated in ACC clinical specimens and cell lines.
RESULTS: Here we identified 1447 differentially expressed circRNAs in primary ACCs as compared with ACAs, of which 849 were significantly upregulated and 598 were downregulated. Differential circRNAs expression between the two groups were validated by qRT-PCR assay. High expression of cricRNA0066659, one of the upregulated circRNAs in ACC, is closely correlated with a low cumulative survival rate and metastatic progression in ACC patients. Furthermore, our experimental analyses identified that cricRNA0066659 specifically binds to miR-506-3p and has a negative correlation with miR-506-3p, indicating that miR-506-3p as a direct target of cricRNA0066659.
CONCLUSIONS: Overall, the differential expression of multiple circRNAs and their clinical significance in ACC tissues as revealed by our study suggests that cricRNA0066659 is a novel metastatic factor and prognostic marker in ACC, we propose that cricRNA0066659 could be used as a potential target in ACC therapy. METHODS: Clinical and genetic data of ACC were retrieved from the ACC dataset of The Cancer Genome Atlas (TCGA) database (n[75). The retrospective analysis of 65 patients diagnosed with adrenocortical carcinoma between 2009 and 2017 in our hospital was performed. The archived, formalin-fixed, paraffin-embedded (FFPE) samples were collected for Immunohistochemical(IHC) analysis of B7-H3. KaplanMeier curve method and log-rank test were used in survival analyses.
RESULTS: The expression level of B7-H3 was significantly correlated with overall survival (HR[2.4, P [ 0.033) and diseasefree survival (HR[3.7, P[0.00049) of ACC patients. Also, the higher expression of B7-H3 was associated with advanced pathological stage of ACC (P [ 0.0276). Furthermore, the analyses of B7-H3-related IHC score validated the positive correlation between B7-H3 and multiple clinical features, such as OS, tumor stage, local recurrence and distant metastases of ACC (P < 0.05).
CONCLUSIONS: B7-H3 plays a crucial role in ACC. The high expression of B7-H3 suggests poor prognosis of ACC patients. Its potential molecular mechanisms warrant further investigation.
